Nasr Iman, Al Kindi Manal, Al Abri Salma, Al Kindi Mahmood, Ansari Zainab, Al Hinai Bushra, Mohamed Ozay, Al Awaidy Salah
Clinical Immunology and Allergy Unit, Royal Hospital, Muscat, Oman.
Chemical Pathologist and Lipidologist Biochemistry Department, Royal Hospital, Muscat, Oman.
Oman Med J. 2025 Mar 31;40(2):e731. doi: 10.5001/omj.2025.60. eCollection 2025 Mar.
Selective immunoglobulin A deficiency (SIgAD) is characterized by an isolated deficiency of serum IgA while immunoglobulin G (IgG) and immunoglobulin M (IgM) levels remain normal. Symptoms range from asymptomatic to recurrent infections. We aimed to determine the prevalence of IgAD and SIgAD among Omani patients undergoing screening for celiac disease.
This cross-sectional study included Omani nationals aged above one year, who were screened for celiac disease with anti-tissue transglutaminase (anti-tTG) IgA at Royal Hospital, Muscat, from January 2005 to December 2023. IgAD was defined as a total serum IgA level below the age-dependent reference range. SIgAD was diagnosed when both IgG and IgM values were within their respective reference limits. The prevalence of IgAD and SIgAD was statistically reviewed.
Of the 9615 individuals who underwent screening for celiac disease, 114 had low IgA levels. The prevalence of IgAD was 1.2%, and among these, 0.4% were confirmed to have SIgAD. The majority were > 14 years. Patients aged 6-14 years and > 14 years were more likely to have IgAD compared to 1-2 years old. Only 39 (34.2%) patients underwent further testing to confirm SIgAD, while the remaining 75 (65.8%) did not undergo follow-up IgG and IgM testing. Among the patients with confirmed SIgAD, 11 (28.2%) underwent further testing with anti-tTG IgG antibody, with only one (9.1%) testing positive for celiac disease as confirmed by esophagogastroduodenoscopy (EGD) and histopathology. Patients with anti-tTG IgG and EGD exhibited a significantly increased risk of low IgA levels. The remaining 28 (71.8%) patients did not undergo further celiac disease workup (anti-tTG IgG antibody, EGD, or genetic testing).
IgAD was present in 1.2% of Omani patients evaluated for celiac disease, and 0.4% had confirmed SIgAD. Referral to an immunologist is recommended when IgG/IgM levels are low or infections are recurrent.
选择性免疫球蛋白A缺乏症(SIgAD)的特征是血清IgA单独缺乏,而免疫球蛋白G(IgG)和免疫球蛋白M(IgM)水平保持正常。症状从无症状到反复感染不等。我们旨在确定阿曼接受乳糜泻筛查的患者中IgAD和SIgAD的患病率。
这项横断面研究纳入了年龄超过1岁的阿曼国民,他们于2005年1月至2023年12月在马斯喀特皇家医院接受抗组织转谷氨酰胺酶(抗tTG)IgA乳糜泻筛查。IgAD定义为血清总IgA水平低于年龄相关参考范围。当IgG和IgM值均在各自参考范围内时,诊断为SIgAD。对IgAD和SIgAD的患病率进行了统计学分析。
在9615名接受乳糜泻筛查的个体中,114人的IgA水平较低。IgAD的患病率为1.2%,其中0.4%被确诊为SIgAD。大多数患者年龄>14岁。与1 - 2岁的患者相比,6 - 14岁和>14岁的患者更有可能患有IgAD。只有39名(34.2%)患者接受了进一步检测以确诊SIgAD,其余75名(65.8%)未进行后续IgG和IgM检测。在确诊为SIgAD的患者中,11名(28.2%)接受了抗tTG IgG抗体的进一步检测,经食管胃十二指肠镜检查(EGD)和组织病理学确诊,只有1名(9.1%)乳糜泻检测呈阳性。抗tTG IgG和EGD患者的低IgA水平风险显著增加。其余28名(71.8%)患者未进行进一步的乳糜泻检查(抗tTG IgG抗体、EGD或基因检测)。
在接受乳糜泻评估的阿曼患者中,1.2%存在IgAD,0.4%确诊为SIgAD。当IgG/IgM水平较低或反复感染时,建议转诊至免疫科医生处。